Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 7
2021 9
2022 4
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC.
de Miguel-Perez D, Ak M, Mamindla P, Russo A, Zenkin S, Ak N, Peddagangireddy V, Lara-Mejia L, Gunasekaran M, Cardona AF, Naing A, Hirsch FR, Arrieta O, Colen RR, Rolfo C. de Miguel-Perez D, et al. Among authors: lara mejia l. J Exp Clin Cancer Res. 2024 Mar 15;43(1):81. doi: 10.1186/s13046-024-02997-x. J Exp Clin Cancer Res. 2024. PMID: 38486328 Free PMC article.
Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancer.
Arrieta O, Bolaño-Guerra LM, Caballé-Pérez E, Lara-Mejía L, Turcott JG, Gutiérrez S, Lozano-Ruiz F, Cabrera-Miranda L, Arroyave-Ramírez AM, Maldonado-Magos F, Corrales L, Martín C, Gómez-García AP, Cacho-Díaz B, Cardona AF. Arrieta O, et al. Among authors: lara mejia l. Front Oncol. 2023 Oct 17;13:1251620. doi: 10.3389/fonc.2023.1251620. eCollection 2023. Front Oncol. 2023. PMID: 37916162 Free PMC article.
Obesity paradox and lung cancer, metformin-based therapeutic opportunity?
Barrios-Bernal P, Hernández-Pedro N, Lara-Mejía L, Arrieta O. Barrios-Bernal P, et al. Among authors: lara mejia l. Oncotarget. 2023 Jul 1;14:670-671. doi: 10.18632/oncotarget.28432. Oncotarget. 2023. PMID: 37395790 Free PMC article. No abstract available.
LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer.
Avilés-Salas A, Díaz-García DA, Lara-Mejía L, Cardona AF, Orozco-Morales M, Catalán R, Hernández-Pedro NY, Rios-Garcia E, Ramos-Ramírez M, Arrieta O. Avilés-Salas A, et al. Among authors: lara mejia l. Curr Oncol. 2022 Dec 26;30(1):333-343. doi: 10.3390/curroncol30010027. Curr Oncol. 2022. PMID: 36661676 Free PMC article.
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population.
Heredia D, Mas L, Cardona AF, Oyervides V, Motta Guerrero R, Galvez-Nino M, Lara-Mejía L, Aliaga-Macha C, Carracedo C, Varela-Santoyo E, Ramos-Ramírez M, Davila-Dupont D, Martínez J, Cruz-Rico G, Remon J, Arrieta O. Heredia D, et al. Among authors: lara mejia l. Lung Cancer. 2022 Dec;174:133-140. doi: 10.1016/j.lungcan.2022.11.002. Epub 2022 Nov 9. Lung Cancer. 2022. PMID: 36379126
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer.
Avilés-Salas A, Flores-Estrada D, Lara-Mejía L, Catalán R, Cruz-Rico G, Orozco-Morales M, Heredia D, Bolaño-Guerra L, Soberanis-Piña PD, Varela-Santoyo E, Cardona AF, Arrieta O. Avilés-Salas A, et al. Among authors: lara mejia l. Thorac Cancer. 2022 Dec;13(23):3362-3373. doi: 10.1111/1759-7714.14695. Epub 2022 Oct 31. Thorac Cancer. 2022. PMID: 36317227 Free PMC article.
25 results